5% Lidocaine and 7.5% Dextrose Injection
Last Updated: May 8, 2017
Status: Current
5% Lidocaine and 7.5% Dextrose Injection
Products Affected - Description
-
5% Lidocaine and 7.5% Dextrose injection, Pfizer
2 mL ampule, 25 count (NDC 00409-4712-01)
Reason for the Shortage
-
- Pfizer has 5% lidocaine and 7.5% dextrose 2 mL ampules on shortage due to manufacturing delays.
- Pfizer is the sole supplier of this combination.
Available Products
-
There are no products available.
Estimated Resupply Dates
-
Pfizer has 5% lidocaine and 7.5% dextrose 2 mL ampules on long-term back order and the company estimates a release date of 2nd quarter 2018.
Related Shortages
| Bupivacaine Injection | Current |
| Bupivacaine with epinephrine Injection | Current |
| Chloroprocaine Injection | Resolved |
| Lidocaine 1% Preservative-Free Injection | Resolved |
| Lidocaine 2% Emergency Syringes | Resolved |
| Lidocaine Hydrochloride and 5% Dextrose injection | Resolved |
| Lidocaine Hydrochloride Oral Topical Solution (Viscous) 2% | Current |
| Lidocaine Topical 4% Solution | Current |
| Lidocaine with Epinephrine Injection | Current |
| Mepivacaine Injection | Resolved |
| Proparacaine Hydrochloride Ophthalmic Solution | Resolved |
| Ropivacaine Injection | Resolved |
| Tetracaine Hydrochloride Ophthalmic Drops | Current |
| Tetracaine Topical Solution | No Longer Available |
Updated
May 8, January 30, 2017; October 31, August 3, 2016, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
